Orbit Subretinal Delivery System for Gene Therapy: Interview with Mike Keane, CTO of Gyroscope Therapeutics
Gyroscope Therapeutics, a retinal gene therapy company, has developed the Orbit subretinal delivery system (SDS). The technology is designed to deliver therapies to the retina without the need for invasive procedures, such as vitrectomies, which invo...
Source: Medgadget - Category: Medical Devices Authors: Conn Hastings Tags: Exclusive Genetics Medicine Source Type: blogs
More News: Age-Related Macular Degeneration (AMD) | Australia Health | Blindness | Clinical Trials | Eyes | Gene Therapy | Genetics | Medical Devices | Men | Opthalmology | Partnerships | Rare Diseases | Sodium Chloride | Study | UK Health | USA Health | Vitamin A